Cannabis in the News, Psychedelic Stocks
Get Ready for the ‘Shroom Boom These days, charismatic budtenders will tell you all about the latest weed tinctures and terpenes in stores across the US. Could the same thing happen with magic mushrooms? So-called “magic” mushrooms contain psilocybin, a...
Cannabis in the News, Investment Opportunities, Legalization, Medical, Psychedelic Stocks, Trending
Biden Administration Anticipated to Approve Psychedelic Therapies Anticipated FDA approval of MDMA and psilocybin treatments outlined in recent Health and Human Services letter With both mental health and drug misuse crises killing thousands of people per day around...
Cannabis in the News, Psychedelic Stocks, Research
Majority of Americans Approve of Psychedelics to Treat Anxiety, Depression and PTSD A new survey conducted by The Harris Poll on behalf of Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF), a leader in new medicines and treatments for a modern world, reports that nearly...
Cannabis in the News, Health, Psychedelic Stocks, Science
Magic mushrooms, also referred to as shrooms, have received a lot of criticism in the past. Fortunately, the clouds of uncertainty have been waved off, especially after many researchers have backed magic mushrooms. But are magic mushrooms really the next best health...
Cannabis in the News, Psychedelic Stocks
North America Continues Leading The Way In Psychedelic Wellness The global psychedelic drugs market remains at an early stage in its life cycle, with most companies currently developing their go-to-market strategy. The market players of psychedelics are involved in...
Cannabis in the News, Investment Opportunities, Psychedelic Stocks, Research, Technology/Innovations
Psychedelic Stocks: Nova Mentis Files Genetic Disease Patent Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based...